TY  - GEN
AU  - Socié,Gérard
AU  - Vigouroux,Stéphane
AU  - Yakoub-Agha,Ibrahim
AU  - Bay,Jacques-Olivier
AU  - Fürst,Sabine
AU  - Bilger,Karin
AU  - Suarez,Felipe
AU  - Michallet,Mauricette
AU  - Bron,Dominique
AU  - Gard,Philippe
AU  - Medeghri,Zakaria
AU  - Lehert,Philippe
AU  - Lai,Chinglin
AU  - Corn,Tim
AU  - Vernant,Jean-Paul
TI  - A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD
SN  - 1528-0020
PY  - 2017///0818
KW  - Acute Disease
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antilymphocyte Serum
KW  - Drug Resistance
KW  - Female
KW  - Graft vs Host Disease
KW  - drug therapy
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Male
KW  - Middle Aged
KW  - Proportional Hazards Models
KW  - Steroids
KW  - therapeutic use
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2016-09-738625
ER  -